SEC
SlamSEC
Search
Browse
Earnings
Allogene Therapeutics, Inc.
Nasdaq:
ALLO
Biological Products, (No Diagnostic Substances)
·
SOUTH SAN FRANCISCO, CA
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Credit & Agreements
material agreements · debt obligations
Credit & Agreements
(8-K)
9 shown
Filed
Description
2/25/25
1.01
Material Agreement
→
5/31/24
1.01
Material Agreement
→
1/31/24
1.01
Material Agreement
→
1/5/24
1.01
Material Agreement
→
12/15/21
1.01
Material Agreement
→
12/15/20
1.01
Material Agreement
→
↓ 3 more
CEO
Chang David D
CFO
Parker Geoffrey M.